Trial · NCT07169409
Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
NCT07169409, Phase 1, Recruiting, Boulder Care
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings. Trials, record NCT07169409. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07169409
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings
- NCT number
- NCT07169409
- Status
- Recruiting
- Phases
- Phase 1
- Enrollment
- 250 participants, estimated
- Lead sponsor
- Boulder Care
- Conditions
- Opioid Use Disorder
- Interventions
- Telemedicine Buprenorphine Treatment
- First posted
- 2025-09-11
- Last updated
- 2025-09-11
Source ClinicalTrials.gov
Registered outcomes4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Intervention Acceptability, Appropriateness, Feasibility | 48 weeks | To measure the participant intervention experience, the study team will utilize qualitative interview data with study participants. These data will be organized into the implementation science categories: Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM), and Feasibility of Intervention Measure (FIM). The study team will determine whether each participant found the intervention to be feasible, acceptable, and/or appropriate. These findings will then be aggregated to better understand how participants experience the implementation of a telemedicine Opioid Use Disorder treatment organization, and will inform a future scaled-up implementation. |
| Secondary | CDC's Health-Related Quality of Life - 4 (CDC HRQOL-4, also called the "Healthy Days Measures") | 48 weeks | Items include: self-rated health, physically unhealthy days, mentally unhealthy days, and activity limitation days. Values: Self-rated health: 1 = Excellent, 2 = Very good, 3 = Good, 4 = Fair, 5 = Poor → Minimum = 1 (Excellent), Maximum = 5 (Poor) Unhealthy days (physical/mental): Range 0-30 days in past 30 days → Minimum = 0, Maximum = 30 Direction: Higher scores = worse outcomes (more unhealthy days or poorer self-rated health). |
| Secondary | Brief Addiction Monitor | 48 weeks | Description: A 17-item multidimensional measure covering three domains: 1. Risk factors (e.g., substance use, craving, triggers) 2. Protective factors (e.g., social support, confidence in recovery) 3. Recovery environment (e.g., housing, employment, stress) Values: * Most items use a 0-30 day timeframe with counts (e.g. "How many days in the past 30 have you used alcohol?" → 0-30). * Some items use Likert-type 0-4 response options (e.g. "Not at all" to "Extremely"). Scoring and Direction: * Higher scores on "risk" items = worse outcomes (e.g., more days using substances, more craving, more risk exposure). * Higher scores on "protective" items = better outcomes (e.g., greater confidence, more supportive contacts). |
| Secondary | Visual Analogue Opioid Craving Scale | 48 weeks | Description: A single-item measure where participants rate their current intensity of craving for opioids by marking a point along a straight line (100 mm in length). The left anchor indicates "No craving at all" and the right anchor indicates "Most intense craving imaginable". Values: Minimum = 0 mm (no craving at all) Maximum = 100 mm (most intense craving imaginable) Direction: Higher scores = worse outcome (greater opioid craving) |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 28851459 | BACKGROUND |
Source PubMed
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| R44DA061386 | Right Tools, Right Time, Right Place: Telehealth for Opioid Use Disorder in Vulnerable Settings | PAPES, STEPHANIE | BOULDER CARE, INC. | NATIONAL INSTITUTE ON DRUG ABUSE | 2024 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07169409
GET https://conductscience.org/api/trials/v1/NCT07169409/registered